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Human peritoneal mesothelial cells synthesize IL-la and j3. We
studied the ability of human peritoneal mesothelial cells (HPMC) to
produce the major pro-inflammatory cytokines interleukin-la (IL-la) and
-3 when stimulated by lipopolysaccharide (LPS), tumor necrosis factor a
(TNFa) or IL-la, or combinations of these three factors. Biological
activity of IL-i was measured by bioassay, and levels of IL-la and -/3 were
determined using specific radioimmunoassays. We found that HPMC are
capable of secreting IL-la and -/3 in response to stimulation by these
substances, but stimulation with a combination of LPS + TNFa, LPS +
tL-la, or TNFa + IL-la, had a marked synergistic effect on cytokine
production. A combination of all three substances together had a signif-
icantly enhanced synergistic effect. Using reverse transcription PCR, we
found a peak in IL-la and /3 mRNA levels three hours after stimulation.
We found that LPS, TNFa and IL-la alone, or in combination, caused an
increase in IL-la and -J3 mRNA levels. Cyeloheximide and actinomycin D
blocked the production of IL-la and -/3 protein, showing that de novo
production of IL-i or synthesis of mRNA stabilizing proteins are needed
after stimulation. We thus conclude that HPMC play an important role in
the amplification of the initial peritoneal inflammatory response which
originates in the peritoneal macrophages, and these findings are of
importance in understanding the peritoneal response to infection in
continuous ambulatory peritoneal dialysis (CAPD) patients.
The main peritoneal cell population consists ot mesothelial
cells. These cells have a structural function, and during peritoneal
dialysis, ultrafiltration and diffusion of solutes occur via this layer
[1]. In the case of peritonitis, leukocytes from blood have to
traverse the mesothelial cells in order to reach the peritoneum.
While the response of peritoneal macrophages to bacterial infec-
tion has been extensively studied, less is known about the contri-
bution of mesothelial cells to the peritoneal inflammatory re-
sponse.
In the initial phase of a bacterial infection, macrophages
produce interleukin-1 (IL-i) and tumor necrosis factor a (TNFa)
in response to contact with bacteria and bacterial products such as
endotoxin [2, 3]. These cytokines initiate the inflammatory cas-
cade, involving vasodilatation, chemotaxis and recruitment of
leukocytes. Only a small number of resident macrophages are
initially present in the peritoneum, and the pro-inflammatory
cytokine signal, released by these macrophages, has to be ampli-
fied and to traverse the mesothelial cell and interstitial layers in
order to reach the endothelial cells and thus stimulate peripheral
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blood leukocytes. In previous studies Topley et al [4, 5] and
Goodman et al [6] have shown that human mesothelial cells
produce IL-6 and IL-8. We reasoned that the mesothelial cells
may thus play a role in the amplification of the cytokine cascade
by themselves producing IL-i when suitably stimulated. We
therefore studied the ability of human peritoneal mesothelial cells
(HPMC) in culture to produce the pro-inflammatory cytokines
IL-la and -/3 when stimulated by endotoxin, TNFa and IL-la.
Our results show that mesothelial cells produced IL-la and IL-1f3
when stimulated by these factors, but the production was greatly
enhanced by stimulation with combinations of endotoxin and
these cytokines. These results suggest that HPMC are capable of
playing an active role in the peritoneal inflammatory response.
Methods
Cell preparation and characterization
Human peritoneal mesothelial cells (HPMC) were isolated
from pieces of omentum of approximately 6 cm2 obtained during
elective abdominal surgery, as previously reported [7]. The pieces
of omentum were washed in phosphate buffered saline (PBS) and
then cut into pieces of approximately 1 mm3. The disaggregation
of the tissue was performed in a 50 ml centrifuge tube using 0.2%
collagenase A (Boehringer Mannheim, Mannheim, Germany) in
M199 medium containing 10% fetal calf serum (FCS), 2 mivi
L-glutamine, 100 U/mI penicillin and 100 mg/ml streptomycin
(unless otherwise stated, all tissue culture reagents were obtained
from Biological Industries, Bet Haemek, Israel), which was con-
tinuously stirred for one hour at 37°C. The mesothelial cells were
washed three times in PBS and then seeded in a 75 cm2 tissue
culture flask (Bibby, Corning, New York, USA) with Ml99
medium containing the above supplements with the addition of
20% pooled human AB serum. The cells were cultured in an
atmosphere of 5% CO2 at 37°C. Some cells were grown in the
absence of human AB serum, but in the presence of the medium
supplement Biogro 2TM (Biological Industries). The rate of growth
and morphology was identical following both treatments. After
reaching confluence cells were trypsinized (trypsin-EDTA, solu-
tion B), washed and diluted in fresh medium. Most experiments
were performed during the third passage. The cells in this passage
had a uniform appearance and micovilli were present. Immuno-
cytochemical analysis using the avidin biotin complex technique
with three intermediate filament antibodies demonstrated that all
the cells coexpressed vimentin (DPC, Los Angeles, California,
USA; CKVNS) and cytokeratins (DPC-CKKHS, stratifying kera-
tin, DPC-CKKLS, simple keratin), which is characteristic of
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mesothelial cells [8]. The cultured cells did not contain cells
expressing CD 68 (Dako, Copenhagen, Denmark; patts-M-8i4), a
macrophage/monocyte marker, or HLA-DR (Becton-Dickinson,
Mountain View, California, USA), and were factor VIII negative.
All tissue culture reagents contained less than 0.025 ng/ml of
endotoxin.
Activation protocols
HPMC (2.5 >< i0 cells/well) were seeded in six well plates
(Bibby) or (0.5 X i0 cells/well) in 24 well plates for RT-PCR
analysis and then incubated for 48 hours until confluence. The
medium was then replaced by medium lacking AB serum, and the
cells were incubated for 16 hours with LPS alone, TNFa or IL-la
alone, or combinations of these substances at varying concentra-
tions, as indicated in the Results section. After 16 hour incuba-
tion, the supernatants were then collected, frozen at —20°C, and
subsequently assayed for IL-la and IL-i /3. For the determination
of cell associated IL-la, cells were washed three times with PBS,
and then frozen in the activation medium. Cell lysates were
obtained by freezing and thawing three times. Total production of
IL-i was determined in the lysate without removing the superna-
tant. During the time course of the experiments, the various
stimuli were not toxic to HPMC, as assessed by lactate dehydro-
genase (LDH) release from the cells, and did not notably alter the
cell number between the different treatments, as assessed by
determination of total LDH activity in lysates. For the mRNA
study, incubations were performed for various lengths of time for
the kinetics experiments, or three hours for combined stimulation.
Some of the experiments were performed after 30 minutes
pre-incubation with cycloheximide (20 jsg/ml; Sigma) or actino-
mycin D (1 Lg/ml; Sigma). Both inhibitor concentrations were not
toxic to the cells during the time course of the experiment as
assessed by LDH release from cells.
IL-i bioassay
IL-i cytotoxic activity of samples on A375 cells was assayed by
measuring neutral red dye uptake [9]. Five X i0 cells per well
were seeded into 96-well plates, then supernatants from activated
HPMC were added and the volume in each well was adjusted to
200 d using Dulbecco's Modified Eagle's Medium (DMEM)
containing 10% FCS, 2 mivi L-glutamine, 100 U/mI penicillin and
100 mg/mI streptomycin. After 72 hours of incubation at 37°C, the
cells were stained with neutral red dye in DMEM medium for two
hours at 37°C. Excess of dye was removed with three washes of
PBS and the dye was then extracted with Sorensen's citrate buffer-
ethanol mixture. Quantitation of dye concentration was per-
formed colorimetrically at 550 nm with a Microelisa Auto-Reader
(Dynatech, Alexandria, Virginia, USA). Recombinant human
IL-ia standards of 0.5 to 1,000 U/mI (DiO assay units) (Hoffman-
La Roche, Nutley, New Jersey, USA) were used to obtain a
calibration curve. In each experiment, medium alone was included
as a negative control, and lysate of LPS-stimulated monocytes
(i06 cells/ml) were included as a positive control. Each sample was
tested in triplicates and at two different concentrations (10% and
50%) to assure testing within the range of the assay. Calculation
of the final IL-i concentration was performed using the ELISA
software package SOFTMAX (Molecular Devices, Menlo Park,
California, USA).
Radioitnmunoassay (RU) of IL-la and -/3
Since the bioassay may not be absolutely specific, we tested the
presence of IL-ia and IL-i/3 using specific RIM (Advanced
Magnetics Inc., Cambridge, Massachusetts, USA). Each sample
was tested in duplicate using the standard protocol of the assay.
Both RIAs for IL-la and IL-1$ are very specific and have no
cross-reactivity with other known cytokines. The lower detection
limits for IL-ia and -/3 were 20 pg/ml and 40 pg/mI, respectively.
Analysis of RNA by reverse transcription—PCR
RAVA extraction. Total RNA was extracted from the cells
according to the RNAzol°M B kit protocol. After three hours of
activation, the HPMC in 24 well plates were washed once with
PBS and then 1 ml of RNAzo1°M B (Biotecx Lab. Inc., Houston,
Texas, USA) was added to each well. The RNAzoITM B solution in
the different wells was then collected in Eppendorf tubes. One
hundred microliters of chloroform was added to each tube, which
was then vortexed for 15 seconds. After five minutes on ice, the
tubes were centrifuged for 30 minutes at 4°C in a Microfuge E
(Beckman Inst. Inc., Palo Alto, California, USA). From each tube
450 td of the upper phase were transferred to a new tube. The
RNA was precipitated by adding 450 d of isopropanol incubation
for 45 minutes on ice, and 15 minutes of centrifugation at 4°C.
The pellet was briefly washed by 70% ethanol, and then dried and
resuspended in 0.3 M sodium acetate and 2.5 volumes of cold
ethanol. The RNA was kept at —70°C.
cDNA preparation
The RNA was precipitated and dried. Each sample was then
dissolved in 12 .d of water, then heated for 10 minutes to 65°C. To
each RNA sample a reverse transcriptase reaction mixture con-
taining 1 of Moloney murine leukemia virus-reverse tran-
scriptase (MMLV-RT) (200 U/pA) (Gibco BRL, Gaithersburg,
Maryland, USA), 4 pA of 5 x reverse transcriptase buffer (Gibco
BRL), 0.5 pA Dfl (0.1 M; Gibco BRL), 0.5 pA RNase inhibitor (40
U/pA; Boehringer Mannheim), 1 1d oligo-d(T) 12-18 mer (40
pmol/itl; Boehringer Mannheim), and 1 pA dNTP's (2.5 nmol/j.d
each nucleotide; Boehringer Mannheim) was added. The tube was
incubated for one hour at 37°C, then the volume of each sample
was adjusted to 60 pA and the enzyme was inactivated by incuba-
tion for 10 minutes at 65°C. Samples of the cDNA preparation
were analyzed for specific cDNA of IL-ia, IL-1f3 and /3-actin by
PCR amplification. Specific primers (Table 1) were purchased
from Clontech (Palo Alto, California, USA).
Five microliters of reverse transcription product was added to
45 IL1 of PCR reaction mixture containing 32.75 pA H2O, 2.5 pA 5'
primer (20 /LM), 2.5 pA 3' primer (20 jiM), 2 1d dNTP's (2.5
nmol/pA each nucleotide; Boehringer Mannheim), 5 pA of 5 X
reaction buffer (Perkin Elmer Cetus, ILS Ltd, London, UK) and
0.25 pA Taq polymerase (2.5 U, Amplitaq©, Perkin Elmer Cetus).
A negative control consisting of the reaction mixture without
cDNA was included with each run. The cDNA was amplified for
25 cycles in a temperature cycler: 90 seconds at 94°C, then 10
cycles of 45 seconds at 94°C, 11/2 minutes at 60°C and one minute
at 72°C. The last 15 cycles were the same, except that each cycle
of the 72°C step was prolonged by 8 seconds. Eight microliter
samples from the various amplified cDNAs, together with 8 pA of
the corresponding f3-actin amplified cDNA were loaded on the
same lane and then run on agarose gels (1.8%) containing
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Table 1. Amplification primers
Gene Oligonucleotide sequence Product size References
IL-in 5' primer 5'-ATGGCCAAAG'VFCCAGACATGTTFG-3' 816 bp [10]
3' primers 5'-GGTTTTCCAGTATCTGAAAGTCAGT-3'
IL-113 5' primers 5'-ATGGCAGAAGTACCTAAGCTCGC-3' 802 bp [11]
3' primer 5'-ACACAAATrGCATGGTGAAGTCAGT1T-3'
f3-actin 5' primer
3' primer
5'-ATGGATGATGATATCGCCGCG-3'
5'-CTAGAAGCA1TfGCGGTGGACGATGGAGGGGCC-3'
1126 bp [121
Fig. 1. IL-i bioactivily produced by HPMC
stimulated by LPS and TNFcx. IL-i bioactivity in
control or stimulated HPMC supernatants was
measured in triplicate by the A375 cytotoxic
assay. Results are mean SE of 6 experiments.
* (experiments vs. unstimulated control) <
0.05, /'p < 0.05 compared to sum of LPS alone
+ TNFn (10 ng/ml) alone.
0.5 g/m1 ethidium bromide. As a DNA size marker we used the
"123 bp ladder" (Gibco BRL). Quantitative evaluation of the
PCR product was performed by video densitometry of the agarose
gel using the UVP GDS 5000 system and software (UVP Inc., San
Gabriel, California, USA). For each sample the emission ratio of
IL-i and /3-actin was calculated. To facilitate comparison between
different assays, the maximal emission ratio value of each exper-
iment was normalized to 1, and all other samples values were
normalized accordingly.
Statistics
The nonparametric Wilcoxon matched pairs test was used to
compare cytokine production between two groups. P values below
0.05 were considered significant.
Results
We initially measured IL-i activity in HPMC supernatants by
the A375 cytotoxic bioassay. As shown in Figure 1, significant IL-i
activity was found in the supernatants after stimulation of HPMC
with either LPS or TNFa. Stimulation with LPS (10 .tg/ml) and
TNFa (10 ng/ml) together resulted in levels of IL-i activity which
were 1.6-fold greater than the sum of the activities following
stimulation with the individual agents, indicating synergism be-
tween LPS and TNFa (P < 0.05).
Figure 2A shows the results of IL-in released by HPMC, as
assessed by specific radioimmunoassays. It can be seen that LPS
caused a small but significant increase in IL-in secretion, while a
minor non-statistically significant rise in secretion of this cytokine
was seen by treatment with 10 nglml of TNFa. Simultaneous
stimulation with the two substances caused considerable synergis-
tic enhancement of IL-ia secretion (P < 0.05).
IL-in and -/3 share the same receptors and have similar
biological activities [2]. While IL-113 is mainly active after secre-
tion, IL-ia, which is mostly stored intracellularly, is active when
associated with the cell membrane [13]. On this basis, cell-
associated IL-ia was examined in lysates of HPMC. As illustrated
in Figure 2B, IL-ia concentration in cell lysates was significantly
enhanced after exposure of HPMC to either LPS or TNFa.
Interestingly enough, a dose-related synergism was again seen in
the cell-lysate preparation when HPMC were treated simulta-
neously with these two substances. It is also worth noting that the
quantity of cell-associated IL-ia was approximately one order of
magnitude greater than that released into the supernatant by
intact cells.
As illustrated in Figure 3A, the mechanisms of induction of
IL-ip in HPMC were found to be similar to those described for
IL-la: IL-1/3 release was significantly increased by stimulation
with LPS, but not with TNFa, whereas a synergistic stimulation
was clearly identified by exposure of the cells to a combination of
LPS + TNFa (P < 0.05).
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Fig. 2. IL-ia production by HPMC following stimulation by LPS and
TNFct (A) IL-la released in control or stimulated HPMC supernatants.
(B) Cell-associated IL-la was measured in cells lysed by repeatedly
freezing and thawing 3 times. IL-la was measured in duplicate by RIA.
Results are mean SE of 5 experiments. *P (experimental vs. unstimu-
lated control) <0.05, Ap < 0.05 compared to sum of LPS alone + TNFs
(10 nglml) alone.
IL-la and -/3 are known to positively regulate each other and
their own expression [14]. We thus investigated the inductive
effect of IL-la, alone or in combination with LPS, on IL-1/3
release by HPMC. As illustrated in Figure 3B, no significant
increase in IL-1/3 secretion was observed by stimulation with 5
nglml of IL-la. However, exposure of HPMC to a combination of
IL-la, at a concentration as low as 0.05 ng/ml, and LPS (10 iWml)
resulted in a significant rise in IL-1/3 secretion. Upon using
increasing concentrations of IL-la while maintaining a constant
level of LPS in the media, IL-1/3 secretion increased in a
dose-dependent fashion. Next, the production of IL-1/3 in cell-
lysates of stimulated HPMC was measured. Figure 4 depicts IL-I /3
production by HPMC when stimulated with increasing concentra-
tions of IL-la or TNFa. It can be seen that both IL-la and TNFa
began to stimulate IL-1/3 production at a concentration of 0.1
nglml, with an optimal stimulation at approximately 5 to 10 ng/ml.
Increasing the concentrations above 50 nglml did not significantly
increase the IL-1/3 production. In addition, IL-1/3 production was
studied at varying concentrations of LPS when 10 nglml of TNFa
Fig. 3. IL-i/I release from HPMC stimulated by (A) LPS and TNFa or (B)
LPS and IL-i a IL-i/I in control or stimulated HPMC supernatants was
measured in duplicate by RIA. Results are mean SE of 6 experiments.
* (experimental vs. unstimulated control) <0.05, Ap < 0.05 compared to
sum of LPS alone + TNFcs (10 ng/ml) alone in panel A or LPS alone +
IL-la (5 ng/ml) alone in panel B.
was present in the incubation media (Fig. 5). It can be seen that
there was significant increase in production of IL-1/3 at a dose of
0.1 g/ml LPS which was not further enhanced by augmenting
LPS concentrations. The addition of TNFs (10 nglml) magnified
the stimulatory effect of LPS and extended the dose response up
to concentration of 10 .tg/ml of LPS. Figure 6 shows the effect of
all three factors, alone and in combination, on IL-1/3 production.
LPS, TNFa and IL-Irs alone all caused a significant increase in
production. However, a combination of at least two of these
factors had a marked synergistic effect, and all three factors
together had a significantly greater effect than that seen with a
combination of two only.
Kinetics of messenger RNA levels of IL-irs and -/3 were studied
by reverse transcription (RT) of RNA isolated from LPS and
TNFa stimulated HPMC for various lengths of time, and then
amplifying the specific cDNAs by PCR. Typical time courses for
induction of IL-I a and -/3 by a combination of TNFa and LPS are
shown in Figure 7. Similar kinetics were obtained after induction
using LPS, TNFa and IL-la alone. As shown in Figure 7, the
transcription of IL-irs was by a single band of 816 bp, of IL-i/I by
a single band of 802 bp, and of /3-actin by a single band of 1128 bp.
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Concentration, ng/mI
Fig. 4. Total IL-i 13 production by HPMC stimulated by increasing concen-
trations of IL-Ia (0) or TNFa (0) for 16 hours of incubation. IL-1/3
production was measured in cell lysates including supernatant in duplicate
by RIA. Results are mean SE of 3 experiments.
IL-la and -/3 could be visualized one hour after stimulation. From
emission densitometry of the bands (Fig. 8; IL-1/f3-actin ratio)
IL-la and -/3 mRNA levels reached a plateau after three to four
hours, began to decline after 12 hours and decreased to approx-
imately 50% at 24 hours.
Twenty-five cycles of PCR were in the exponential phase of
amplification, thus permitting comparison of the level of mRNA
between different samples. Under these conditions, a linear
dose-response of the PCR product to increasing doses of cDNA
was also found. IL-la and -/3 amplification products were com-
pared to the /3-actin housekeeping gene transcripts amplified from
the same samples. Similar results were found for IL-irs and -/3
mRNA levels. Low constitutive mRNA levels of both cytokines
could be identified in most experiments in untreated HPMC. As
can be seen in Figure 9 and from the emission ratio calculated in
Figure 10, induction with LPS, TNFa and IL-la for three hours
resulted in increased IL-la and -/3 mRNA levels.
Under the condition of this experiments and in additional
experiments with shorter (2 hr) or longer (16 hr) exposure to the
various combination of stimulants, no notable additive effect was
seen in iL-la and -f3 mRNA levels. Inhibition of transcription by
actinomycin D, and translation by cycloheximide, resulted in
inhibition of IL-irs and -/3 production in HPMC lysates (Fig. 11).
This indicated that release of IL-i from stimulated HPMC was
dependent on de novo RNA transcription and protein synthesis,
and possibly the presence of mRNA stabilizing proteins.
Discussion
The main clinical problem associated with continuous ambula-
tory peritoneal dialysis remains the relatively high incidence of
bacterial peritonitis [15, 161. The resident population of perito-
LPS, pg/mi
Fig. 5. Total IL -1 /3 production by HPMC, measured in cell lysate, stimu-
lated for 16 hours by increasing Concentrations of LPS, in the presence (•; JO
nglmi) or absence (0) of TNFa. IL-i/I production was measured in cell
lysates including supernatant in duplicate by RIA. Results are mean SE
of 3 experiments.
Fig. 6. Total IL-i /3 production by HPMC measured in cell lysate. HPMC
were untreated, or stimulated with LPS, TNF or IL-la in the concentra-
tions and combinations shown in the figure. IL-I/I production was
measured in cell lysates including supernatant in duplicate by RIA.
Results are mean SE of 5 experiments. P (experimental vs. unstimu-
lated control) < 0.05, Ap < 0.05 compared to sum of the according
stimulants alone, AAp < 0.05 compared to sum of LPS alone + TNFa (10
ng/ml) alone + IL-la (5 nglml) alone.
neal cells consists of macrophages, which constitute the first line
of defense in the case of infection [17]. Subsequently, a large
number of leukocytes are mobilized from the circulation. The
initial response of peritoneal macrophages is thus critical, and
these cells have been shown in vitro to produce pro-inflammatory
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Fig. 7. Time kinetics of IL-la (A) and IL -1 f3
(B) mRNA levels after stimulation. HPMC
were stimulated with LPS (10 .tg/ml) and
TNFa (10 ng/ml) for various lengths of time.
RT-PCR of RNA samples of activated HPMC
were performed (25 cycles). On each lane the
IL-i product with the respective 13-actin
product as the control were loaded, and
analyzed on 1.8% agarose gel. Stimulation
time and the according bands are indicated
on the figures. Two additional preparations
from different donors were studied and
yielded similar results (emission IL-1/L3-actin
ratio data is shown in Fig. 8).
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Fig. 8. Average SE ofIL-l/13-actin emission
ratio of three RT-PCR time kinetics of (A) IL-la
(A) and (B) IL-Ip (•) mRNA levels after
stimulation. HPMC were stimulated with LPS
(10 .tg/ml) and TNFa (10 ng/ml) for various
length of time. RT-PCR products of
experiments described in Fig. 7 were separated
on ethidium bromide (0.5 tg/ml) agarose gels.
The ethidium bromide emission intensity of the
bands were evaluated using UVP GDS 5000
video system and software (UVP Inc.). The
maximal emission ratio of each experiment was
normalized to 1 and all the other samples were
adjusted accordingly, allowing comparison
between the experiments.
cytokines, including IL-la and -13, and TNF [2, 3], which initiate
the inflammatory response. However, the main cell population of
the peritoneal cavity consists of mesothelial cells, which essentially
form a cellular barrier separating the peritoneal capillaries from
the peritoneal cavity, and across which dialysis occurs. We hypoth-
esized that these cells may participate in the peritoneal inflam-
matory response by secretion of cytokines. In this context, Topley
et al have demonstrated that HPMC are capable of synthesizing
IL-6 [4] and IL-8 [5], and Goodman et al have shown that pleural
mesothelial cells are capable of producing IL-8 [6]. We thus
investigated the ability of HPMC to produce IL-la and -13, and
found that HPMC are capable of producing these two major
pro-inflammatory cytokines. Using both bioassay and specific
radioimmunoassays, no significant IL-i activity or IL-la or -13
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Fig. 9. IL-la (A) and IL-i/3 (B) mR/VA levels
in LPS, TNFa and IL-i a stimulated HPMC.
HPMC were stimulated for 3 hour with LPS
(10 jig/mI), TNFa (JO og/mI), IL-la (5 ng/ml)
or combination of those factors as indicated.
On each lane the IL-i RT-PCR products (25
cycles) with the respective /3-actin products as
the control were loaded, and analyzed on 1.8%
agarose gel. In total three experiments from
different donors in duplicate were performed
and yielded similar results (the emission data is
presented in Fig. 10).
could be shown in the absence of stimulation. We stimulated the
cells by attempting to mimic the in vivo situation pertaining in an
episode of peritonitis. LPS is the main pro-inflammatory product
of gram negative bacteria, and peritoneal macrophages secrete
IL-i and TNFa upon contact with bacteria. We thus stimulated
HPMC with LPS, IL-ia, or TNFa alone, or combinations of all
three substances. Both LPS and TNFa alone stimulated produc-
tion of IL-i, measured by bioassay, and of IL-la, as measured by
radioimmunoassay, but stimulation by both substances together
had a marked synergistic effect, increasing cytokine activity in a
dose-related fashion. However, in the ease of IL-l/3, significant
release was seen following incubation with LPS but not with IL-la
or TNFa alone. A marked synergistic and dose related effect on
IL-1f3 production was seen on combining LPS with one of these
two agents, and combination of all three agents had the maximum
effect. The mechanism of the synergism with LPS is unclear. IL-la
or TNFa have separate cellular receptors [2], and these agents
may affect different intracellular signaling pathways, thus causing
an enhanced signal when used in conjunction.
A high concentration of cell-associated IL-la was found in
stimulated HPMC, similar to findings in macrophages, lIbroblasts
and other cells in which membrane-bound IL-la has been dem-
onstrated [13, 18—20]. The role of cell-associated cytokines has
not been clearly defined. Cell-associated IL-la may amplify the
inflammatory response during the cell destruction occurring in
acute inflammation. It may also have a local inflammatory role
when present on the cell membrane, as reported for IL-I a [201.
Transcription of IL-la and -/3 genes could be demonstrated in
stimulated cells by the RT-PCR method. IL-la and IL-I /3 mRNA
levels reach peak levels three to four hours after stimulation and
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Fig. 10. Average SE of IL-l//3-actin emission
ratio of three RT-PCR experiments (in duplicates)
of (A) IL-la and (B) IL-I 13 after various HPMC
stimulation. 1-IPMC were stimulated for 3 hours
with LPS (10 g/ml), TNFa (10 ng/ml), IL-la
(5 ng/ml) or combination of those factors as
indicated. RT-PCR products of experiments
described in Fig. 9 were separated on ethidium
bromide (0.5 Wml) agarose gels. The ethidium
bromide emission intensity of the bands were
evaluated using UVP GDS 5000 video system
and software (UVP Inc.). The maximal emission
ratio of each experiment was normalized to 1,
and all the other samples were adjusted
accordingly, allowing comparison between the
experiments.
begin to decrease approximately after 12 hours. In both cases we
found in most experiments that basal mRNA levels were present
without stimulation, showing that the IL-la and -/3 genes are
transcribed at a low constitutive level. De novo RNA synthesis is
probably essential for IL-i production after stimulation, as shown
by the effect of actinomycin D. The possibility that RNA stabiliz-
ing proteins are also required cannot be excluded. Stimulation
with LPS, TNFa, IL-la or combinations of two or three of these
agents together increased the IL-la and -/3 mRNA above that of
the untreated cells. Since we could not find clear differences in
mRNA of IL-la or -/3 when combinations of stimuli were used,
the main regulatory step in the synthesis of IL-la and IL-113 may
occur at the post-transcriptional level. This finding of a dissocia-
tion between transcription and translation of the IL-ia and ../3
genes is consistent with the findings of Schindler Ct al in human
peripheral blood mononuclear cells [21, 22j. These workers found
a dissociation between transcription and translation of IL-1/3 in
these cells. Thus, incubation of mononuclear cells in glass or
plastic vessels itself caused expression of IL-113 mRNA, without
detectable IL-1/3 synthesis. To obtain translation, a stimulus with
LPS was required. In the light of these results, we cannot exclude
the possibility that the apparent constitutive expression of IL-la
and -/3 mRNA which may have resulted from adherence of HPMC
to the plastic tissue culture vessels used.
In summary, we have shown that HPMC are capable of
participating in the peritoneal inflammatory process in response
to bacterial endotoxin (LPS) and macrophage cytokines (IL-i and
TNFa). Thus, HPMC may amplify the limited inflammatory signal
initiated by macrophages. IL-la and -/3 secreted from HPMC may
Fig. 11. Effect of inhibition of transcription or translation on IL-la (0) and
13 (0) production. HPMC were exposed for 30 mm to actinomycin D (1
g/ml) or cycloheximide (20 jsgJml), then stimulated with LPS (10 tg/ml)
and TNFa (10 ng/ml) for 16 hours. IL-la and -13 production was measured
in cell lysates including supernatant in duplicate by RIA. Results are mean
SD of 2 experiments.
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act locally or systematically to induce the release of IL-i and other
cytokines from HPMC themselves or other cells, such as endo-
thelial cells.
It seems likely that the production of these cytokines by HPMC
at the onset of bacterial peritonitis encourages chemotaxis of
leukocytes, leukocyte adhesion and recruitment, and activation of
macrophages as well as T and B lymphocytes, and thus that
HPMC may play an active role in the inflammatory response of
the peritoneum.
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